RU2016106521A - Method of anesthesia in dentistry - Google Patents

Method of anesthesia in dentistry Download PDF

Info

Publication number
RU2016106521A
RU2016106521A RU2016106521A RU2016106521A RU2016106521A RU 2016106521 A RU2016106521 A RU 2016106521A RU 2016106521 A RU2016106521 A RU 2016106521A RU 2016106521 A RU2016106521 A RU 2016106521A RU 2016106521 A RU2016106521 A RU 2016106521A
Authority
RU
Russia
Prior art keywords
dose
anesthesia
dentistry
local
dexketoprofen
Prior art date
Application number
RU2016106521A
Other languages
Russian (ru)
Other versions
RU2714440C2 (en
RU2016106521A3 (en
Inventor
Петр Александрович Попов
Алексей Николаевич Морозов
Андрей Валерьевич Сущенко
Кристине Мелконовна Никогосян
Александр Сергеевич Сарычев
Андрей Юрьевич Проскуряков
Original Assignee
Петр Александрович Попов
Алексей Николаевич Морозов
Кожевников Виталий Владимирович
Толмачев Алексей Юрьевич
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Петр Александрович Попов, Алексей Николаевич Морозов, Кожевников Виталий Владимирович, Толмачев Алексей Юрьевич filed Critical Петр Александрович Попов
Priority to RU2016106521A priority Critical patent/RU2714440C2/en
Publication of RU2016106521A publication Critical patent/RU2016106521A/en
Publication of RU2016106521A3 publication Critical patent/RU2016106521A3/ru
Application granted granted Critical
Publication of RU2714440C2 publication Critical patent/RU2714440C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ обезболивания в стоматологии, отличающийся тем, что используют однократное внутривенное болюсное введение одного из следующих препаратов нестероидных противовоспалительных соединений - кеторолака трометамина в дозе 15-75 мг, или метамизола натрия в дозе 500-2500 мг, или кетопрофена в дозе 50-250 мг, или декскетопрофена в дозе 25-125 мг, или лорноксикама в дозе 4-20 мг - в период времени от момента, составляющего от 3 ч до 15 с до начала выполнения местной анестезии и собственно стоматологического вмешательства, до момента начала разрешения местной интраоперационной анестезии.A method of analgesia in dentistry, characterized in that they use a single intravenous bolus injection of one of the following drugs of non-steroidal anti-inflammatory compounds - ketorolac tromethamine at a dose of 15-75 mg, or metamizole sodium at a dose of 500-2500 mg, or ketoprofen at a dose of 50-250 mg, or dexketoprofen at a dose of 25-125 mg, or lornoxicam at a dose of 4-20 mg - during the period from the moment of 3 hours to 15 seconds before the start of local anesthesia and the actual dental intervention, until the start of local resolution intraoperative anesthesia.
RU2016106521A 2016-02-25 2016-02-25 Method of anaesthesia in dentistry RU2714440C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2016106521A RU2714440C2 (en) 2016-02-25 2016-02-25 Method of anaesthesia in dentistry

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2016106521A RU2714440C2 (en) 2016-02-25 2016-02-25 Method of anaesthesia in dentistry

Publications (3)

Publication Number Publication Date
RU2016106521A true RU2016106521A (en) 2017-08-30
RU2016106521A3 RU2016106521A3 (en) 2018-10-04
RU2714440C2 RU2714440C2 (en) 2020-02-14

Family

ID=59798603

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016106521A RU2714440C2 (en) 2016-02-25 2016-02-25 Method of anaesthesia in dentistry

Country Status (1)

Country Link
RU (1) RU2714440C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2746295C1 (en) * 2020-09-09 2021-04-12 Петр Александрович Попов Method for pain relief and sedation in dentistry

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA9062U (en) * 2004-11-25 2005-09-15 Ukrainian Res Inst Of Naval Me Method for anesthesia in implantation of complete hip joint prosthesis
US8956636B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Methods and compositions for treating postoperative pain comprosing ketorolac
RU2540905C1 (en) * 2013-07-26 2015-02-10 Петр Александрович Попов Method for preventing pain and psychoemotional responses in endovascular x-ray surgeries

Also Published As

Publication number Publication date
RU2714440C2 (en) 2020-02-14
RU2016106521A3 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
CY1119886T1 (en) METHOD FOR MANUFACTURING OF A PHARMACEUTICAL COMPOSITION IN FORM OF PROLONGED RELEASE TABLET CONTAINING pirfenidone and uses thereof regression CHRONIC RENAL DEFICIENCY, KAPSIKIS SYSPASIS udder of hepatic INOSIS IN HUMANS
EA201290026A1 (en) A METHOD FOR TREATING A PATIENT THAT HAS A RISK OF DEVELOPMENT OF ANALISM ASSOCIATED WITH THE RECEPTION OF NONSTEROID ANTI-INFLAMMATORY MEDIA
RU2018114447A (en) INTRODUCTION OF CFTER DUTERED AMPLIFIERS
EA201691454A1 (en) COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING
JP2015057451A5 (en)
UY35624A (en) USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE
MA39366A1 (en) Fluid delivery pen comprising a final dose stop and improved dosage elements
DK2043637T3 (en) Methods and Medications for the Administration of ibuprofen
HRP20211046T1 (en) Uses of benzimidazole derivative for nocturnal acid breakthrough
RU2016127558A (en) STEROID COMPOUND FOR USE IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY
JP2019532634A5 (en)
FI2683245T4 (en) Methods and compositions for treating depression using cyclobenzaprine
JP2016515623A5 (en)
RU2018146504A (en) Treatment of intrahepatic cholestatic diseases
JP2014148552A5 (en)
AR099299A1 (en) INHIBITOR OF THE CHOLESTERILE ESTER TRANSFER PROTEIN (CETP) AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
JP2017507142A5 (en)
JP2017512194A5 (en)
RU2016106521A (en) Method of anesthesia in dentistry
JP2014058509A5 (en)
JP2020515523A5 (en)
CO2018009543A2 (en) Extended release pharmaceutical composition comprising cysteamine or salt thereof
CO2019003808A2 (en) Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof
ES2459444T3 (en) Synergistic combination of analgesic compounds
MX2018005298A (en) Dosage regimen for a phosphatidylinositol 3-kinase inhibitor.

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20190215

HE9A Changing address for correspondence with an applicant
FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20190923

PD4A Correction of name of patent owner